MedTrace Logo

Intravenous Ketamine and Postoperative Pain Following Cesarean Section.

NCT03018301 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to investigate the analgesic effect of low-dose intravenous ketamine in pregnant mothers undergoing cesarean section under Bupivacaine spinal anesthesia.

Conditions

  • Postoperative Pain

Interventions

DRUG

Ketamine

will receive 0.25 mg/kg intravenous ketamine diluted with normal saline to 20 ml delivered over 10 minutes.

OTHER

Normal saline

will receive intravenous 20 ml of normal saline, delivered over 10 minutes.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Israa M Sayed · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03018301 on ClinicalTrials.gov